Downstream effectors of the Wnt pathway were also found to be reduced following AD + TS treatment including phospho-MAPK, phospho-Src, and phospho-AKT, indicating that the processes of cell growth and proliferation controlled by these pathways are diminished by AD + TS treatment (Fig. 6B). Here, AKT1 is linked to Alzheimer disease.